Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CTSU E1208 Principal Investigator: Tan, Benjamin
Title: A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion
Phase: III Disease Site: Liver
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to see if adding the oral chemotherapy pill, sorafenib (Nexavar), to localized chemotherapy (chemoembolization) to the liver will help patients to live longer than treatment with localized chemotherapy to the liver without sorafenib.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)